Clinical Trials
8 trialsNCT01712490 2026-02-27
A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma
Takeda
Phase 3 Completed
NCT00993512 2019-04-29
Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous Cancer
PCI Biotech AS
Phase 1 Completed
NCT00198263 2017-10-03
Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer
Inovio Pharmaceuticals
Phase 4 Completed
NCT00198276 2017-10-03
Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer
Inovio Pharmaceuticals
Phase 4 Completed
NCT01060904 2014-12-18
A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma
Seagen Inc.
Phase 1 Completed
NCT01872923 2014-06-16
Dose Escalating Study for Amphinex-based PCI of Bleomycin.
PCI Biotech AS
Phase 1 Completed
NCT00002093 2005-06-24
A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.
NIH AIDS Clinical Trials Information Service
Phase 3 Completed
NCT00002105 2005-06-24
Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma
NIH AIDS Clinical Trials Information Service
Phase 3 Completed